Results 111 to 120 of about 8,233 (133)

Expression of CD38 on resting peripheral iNKT cells defines an immature subpopulation with distinct functionality in humans. [PDF]

Immunol Cell Biol
Menne C, Tavakolinia N, Perriman L, Moskorz W, Cosmovici C, Walker A, Olejnik L, Raba K, Du MR, Rossello FJ, Konstantinov IE, Berzins SP, Pellicci DG, Timm J.   +13 more
europepmc   +1 more source

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.

Blood
Ren H, Elliott N, Lye B, Sharif Shohan MU, Cross JW, Field L, Ponnusamy K, Rice S, Jackson T, Leontari I, El Ouazzani N, Thomas R, Inglott S, Bartram J, Smith O, Bond J, Roberts IAG, Halsey C, Bashford-Rogers R, Milne TA, Roy A, Karadimitris A.   +21 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

People also looked at

Frontiers in Immunology, 2023
Ivo Tews, Doctor Salah Mansour, Ali Roghanian   +2 more
exaly  

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

Cell Reports Medicine, 2021
Lili Yang, Xi Wang, Matteo Pellegrini
exaly  

Distinct iNKT Cell Populations Use IFNγ or ER Stress-Induced IL-10 to Control Adipose Tissue Homeostasis

Cell Metabolism, 2020
Michael B Brenner, Ayano C Kohlgruber, Lydia Lynch   +2 more
exaly  

License to Kill: When iNKT Cells Are Granted the Use of Lethal Cytotoxicity

International Journal of Molecular Sciences, 2020
Francesco Strati, Federica Facciotti, Angélica Díaz-Basabe   +2 more
exaly  

Brief homogeneous TCR signals instruct common iNKT progenitors whose effector diversification is characterized by subsequent cytokine signaling

Immunity, 2021
Maria Colomé Tatché, Thorsten Buch, Rupert Ollinger   +2 more
exaly  

Using agonists for iNKT cells in cancer therapy

Molecular Immunology, 2021
Gavin F Painter, Ian F Hermans, Olivia K Burn   +2 more
exaly